Partner sites:EURES

Director of Diabetes Purification Development

This offer has expired

You can not apply any more to this job offer. Please go to the list of all available jobs to find a still valid offer.

The job offer is available for the following event:

Novo Nordisk A/S

Gladsaxe, 1 stilling

- Research & Development
- Denmark - Bagsværd

Are you ready for a position with impact on the future of Novo Nordisk? Do you have a scientific background and a strong track record managing people and complex projects? If so, we can offer you a rarely posted position, where research, development and management come together, and where your work will be changing the lives of millions of people living with diabetes. In this job, you will play a vital role in the diabetes development portfolio at Novo Nordisk, working with process development of API candidates from early development to late phase III.

About the department
The department, Diabetes Purification Development consist of two teams and 40 dedicated and highly skilled employees. The department is anchored in CMC API Development and is part of Novo Nordisk Research & Development organization and is responsible for process development of new drug substance candidates for the entire diabetes development portfolio at Novo Nordisk. This includes recovery and downstream purification of yeast and E. coli processes and purification of synthetic peptides. We do so in close collaboration with the research unit as well as the pilot facilities responsible for manufacturing the proteins used for clinical trials.

CMC API Development consist of approximately 470 employees and is responsible for drug substance manufacturing – processing development of new product candidates for the entire portfolio of Novo Nordisk. This includes microbiological fermentation, mammalian cell culture, chemical syntheses, recovery and purification. Diabetes API Development is one of four VP areas in CMC API Development and Diabetes Purification Development is a department in Diabetes API Development.

The job
You will play a key role in CMC API Development, supporting API projects that proceed through the clinical pipeline. Currently, the department handles more than 25 different projects spanning from early development to late phase III. As Director you will have 2 team leaders and several API project leaders as direct reports and you will have the overall responsibility for the department in all aspects. You make sure that we have the right resources and competences and that the right prioritization is made between the different projects.

You will lead changes supporting a LEAN culture where continuous improvement and science is a natural part of everyday work. You will report to the VP of Diabetes API Development and be a member of the Diabetes API management team, which consists of five department managers, who are working closely together.

Qualifications
You have solid managerial experience from a similar role in a pharmaceutical company and your experience is backed by a Master’s or PhD degree within a relevant field of expertise. You have extensive working experience from the pharmaceutical industry and you are familiar with protein chemistry as well as with the techniques involved in protein purification.

You set and communicate a clear direction and you have an excellent overview, a structured mind-set, a dedicated way of working and the ability to balance when to compromise and when to stand firm. You are ambitious and display a high level of personal engagement, drive, persistence and integrity. You possess excellent planning skills as well as the ability to build relations with stakeholders. You find it rewarding to work towards reaching your goals while also engaging in activities beyond your own department.

At Novo Nordisk, we use our skills, dedication and ambition to help people with diabetes, bleeding disorder or growth hormone deficiency. We offer the chance to be part of a truly global work place, where passion and engagement are met with opportunities for professional and personal development.

Contact
For further information, please contact Rune Severinsen at 30799491.

Deadline
11 November 2015.